(Q44151604)

30 November 2017

title

Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock (English)

1 reference

30 November 2017

1 reference

1 reference

4

Ohman EM

1 reference

30 November 2017

Kovack PJ

1

1 reference

30 November 2017

Rasak MA

series ordinal

2

1 reference

30 November 2017

Bates ER

series ordinal

3

1 reference

30 November 2017

Stomel RJ

series ordinal

5

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

Journal of the American College of Cardiology

30 November 2017

published in

1 reference

30 November 2017

volume

29

1 reference

30 November 2017

issue

7

1 reference

30 November 2017

page(s)

1454-1458

1 reference

Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2982537-5

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2982537-5

7 January 2021

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2982537-5

7 January 2021

Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2982537-5

7 January 2021

Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2982537-5

7 January 2021

Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2982537-5

7 January 2021

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2982537-5

7 January 2021

Randomized controlled trial of intraaortic balloon counterpulsation in early myocardial infarction with acute heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2982537-5

7 January 2021

Results of a randomized prospective trial of intraaortic balloon counterpulsation and intravenous nitroglycerin in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2982537-5

7 January 2021

Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2982537-5

7 January 2021

Complications of intraaortic balloon counterpulsation insertion in patients receiving thrombolytic therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2982537-5

7 January 2021

Safety of intraaortic balloon counterpulsation in patients with acute myocardial infarction receiving streptokinase intravenously

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2982537-5

7 January 2021

Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2982537-5

7 January 2021

Prognosis in cardiogenic shock after acute myocardial infarction in the intervencional era

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2982537-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2982537-5

1 reference

7 January 2021

Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2982537-5

7 January 2021

Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2982537-5

7 January 2021

Myocardial salvage by the use of reperfusion and intraaortic balloon pump: experimental study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2982537-5

7 January 2021

Arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2982537-5

7 January 2021

10.1016/S0735-1097(97)82537-5

Identifiers

DOI

1 reference

30 November 2017

1 reference